Actionable news
All posts from Actionable news

MARINUS PHARMACEUTICALS: Public Offering Of Common Stock

The following excerpt is from the company's SEC filing.

RADNOR, PA, November 5, 2015 (Globe Newswire) Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS) (Marinus or the Company) today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. Jefferies LLC and RBC Capital Markets, LLC are acting as joint bookrunning managers for the offering. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

The Company currently intends to use the net proceeds of this offering to advance the preclinical and clinical development of ganaxolone, including trials for the Companys ganaxolone IV program, and regulatory, research and development, pre-commercial, general and administrative and manufacturing expenses and for working capital and general corporate purposes.

The securities described above are being offered by the Company pursuant to a shelf registration statement previously filed with and declared effective by the Securities and Exchange Commission on August 25, 2015. The offering will be made only by means of the written prospectus and prospectus supplement that form a part of the registration statement. Copies of the preliminary prospectus supplement and the accompanying prospectus relating to the securities being offered may also be obtained from Jefferies LLC., Attention: Equity Syndicate Prospectus Department, 520 Madison Avenue, 2nd Floor, New York, NY 10022, via telephone at 877-821-7388 or email at; or from RBC Capital Markets, LLC, Attention: Equity Syndicate, 200 Vesey Street, 8th Floor, New York, NY 10281-8098, via telephone at 877-822-4089 or email at

This press release does not constitute an offer to sell or the solicitation of offers to buy any securities of

Marinus being offered

, and shall not constitute...